Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004

被引:459
作者
Hemelaar, Joris
Gouws, Eleanor
Ghys, Peter D.
Osmanov, Saladin
机构
[1] WHO, UNAIDS, HIV Vaccine Initiat, CH-1211 Geneva 27, Switzerland
[2] Univ Oxford, Magdalene Coll, Oxford OX1 4AU, England
关键词
circulating recombinant form; distribution; genetic variability; HIV; molecular epidemiology; recombinants; subtypes;
D O I
10.1097/01.aids.0000247564.73009.bc
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To estimate the global and regional distribution of HIV-1 subtypes and recombinants in 2004. Design: A study was conducted in which molecular epidemiological data on HIV-1 subtype distribution in individual countries were combined with country-specific estimates of the number of people living with HIV. Methods: HIV-1 subtype data were collected for 23 874 HIV-1 samples from 70 countries, which together accounted for 89% of all people living with HIV worldwide in 2004. The proportions of HIV-1 infections due to various subtypes detected in each country were combined with the number of HIV infected people in the respective countries to generate regional and global HIV-1 subtype distribution estimates. Results: Subtype C accounted for 50% of all infections worldwide in 2004. Subtypes A, B, D and G accounted for 12%, 10%, 3% and 6%, respectively. The subtypes F, H, J and K together accounted for 0.94% of infections. The circulating recombinant forms CRF01_AE and CRF02_AG each were responsible for 5% of cases, and CRF03_AB for 0.1%. Other recombinants accounted for the remaining 8% of infections. All recombinant forms taken together were responsible for 18% of infections worldwide. Conclusion: Combining data on HIV-1 subtype distribution in individual countries with country-specific estimates of the number of people living with HIV provided a good method to generate estimates of the global and regional HIV-1 genetic diversity in 2004. The results could serve as an important resource for HIV scientists, public health officials and HIV vaccine developers.
引用
收藏
页码:W13 / W23
页数:11
相关论文
共 34 条
[21]   Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide [J].
Pieniazek, D ;
Rayfield, M ;
Hu, DJ ;
Nkengasong, J ;
Wiktor, SZ ;
Downing, R ;
Biryahwaho, B ;
Mastro, T ;
Tanuri, A ;
Soriano, V ;
Lal, R ;
Dondero, T .
AIDS, 2000, 14 (11) :1489-1495
[22]  
Renjifo B, 2001, J HUMAN VIROL, V4, P16
[23]  
Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d
[24]   Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT [J].
Swanson, P ;
de Mendoza, C ;
Joshi, Y ;
Golden, A ;
Hodinka, RL ;
Soriano, V ;
Devare, SG ;
Hackett, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :3860-3868
[25]   Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission [J].
Tàpia, N ;
Franco, S ;
Puig-Basagoiti, F ;
Menéndez, C ;
Alonso, PL ;
Mshinda, H ;
Clotet, B ;
Saiz, JC ;
Martínez, MA .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :607-613
[26]   Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy [J].
Thomson, MM ;
Pérez-Alvarez, L ;
Nájera, R .
LANCET INFECTIOUS DISEASES, 2002, 2 (08) :461-471
[27]   Differences in chemokine coreceptor usage between genetic subtypes of HIV-1 [J].
Tscherning, C ;
Alaeus, A ;
Fredriksson, R ;
Björndal, Å ;
Deng, HK ;
Littman, DR ;
Fenyö, EM ;
Albert, J .
VIROLOGY, 1998, 241 (02) :181-188
[28]  
[UNAIDS WHO], 2003, GUID COND HIV SENT S
[29]  
UNAIDS/WHO, GUID 2 GEN HIV SURV
[30]   Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? [J].
Walker, N ;
Grassly, NC ;
Garnett, GP ;
Stanecki, KA ;
Ghys, PD .
LANCET, 2004, 363 (9427) :2180-2185